New study aims to uncover hidden liver risks in pregnant women
NCT ID NCT07300345
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will look at 80 pregnant women with signs of liver issues, such as high liver enzymes or bilirubin, to find out which liver disorders are most common and how they affect both mother and baby. Researchers will track changes in liver health over time using blood tests and symptom checks. The goal is to improve early detection and care for liver problems during pregnancy.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could point toward better screening and management guidelines for liver problems during pregnancy, potentially reducing complications for mothers and babies.
- What could go wrong
- This is an early observational study with only 80 participants at a single hospital, so findings may not apply to all pregnant women. It does not test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER BIOMARKERS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.